【24h】

Nanoemulsion Formulations for Improved Oral Delivery of Poorly Soluble Drugs

机译:改善难溶性药物口服给药的纳米乳剂

获取原文
获取原文并翻译 | 示例

摘要

The objective of this study was to develop nanoemulsion formulations for enhancement of oral bioavailability of paclitaxel, a model hydrophobic drug and P-glycoprotein substrate. The oil-in-water (o/w) nanoemulsions were made with pine nut oil as the internal oil phase, egg lecithin as the primary emulsifier, and water as the external phase. Stearylamine and deoxycholic acid were used to impart positive and negative charge to the emulsions, respectively. The formulated nanoemulsions had a particle size range of 90-120 nm and zeta potential ranging from +34 mV to -56 mV. Following oral administration to C57BL/6 mice, a significantly higher concentration of paclitaxel was observed in the systemic circulation when administered in the nanoemulsion relative to control aqueous solution. The results of this study suggest that nanoemulsions are promising novel formulations that can enhance the oral bioavailability of poorly soluble drugs.
机译:这项研究的目的是开发纳米乳剂,以增强紫杉醇(一种模型疏水性药物和P-糖蛋白底物)的口服生物利用度。以松子仁油为内油相,卵磷脂为主要乳化剂,水为外相来制备水包油(o / w)纳米乳剂。硬脂胺和脱氧胆酸分别用于赋予乳液正电荷和负电荷。配制的纳米乳液的粒度范围为90-120 nm,ζ电势范围为+34 mV至-56 mV。口服给予C57BL / 6小鼠后,与对照水溶液相比,当以纳米乳剂形式给药时,在全身循环中观察到紫杉醇的浓度明显升高。这项研究的结果表明,纳米乳剂是有前途的新型制剂,可以提高难溶性药物的口服生物利用度。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号